At a glance
- Originator Wyeth
- Class Antibacterials; Beta-lactams; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 22 Mar 2002 Discontinued - Preclinical for Bacterial infections in USA (PO)
- 12 Jan 2000 New profile
- 12 Jan 2000 Preclinical development for Bacterial infections in USA (PO)